Codexis to Participate in Jefferies Healthcare Conference
May 24, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Healthcare...
Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
May 10, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO)...
Codexis Announces New Employment Inducement Grants
May 08, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to five new employees as...
Codexis Reports First Quarter 2023 Financial Results
May 04, 2023 16:05 ET
|
Codexis, Inc.
CDX-7108 Clinical Development Program Remains on Track Estimated Cash Runway Through End of 2024 Funds Important Upcoming Milestones Company Reiterates 2023 Total Revenue Guidance with...
Codexis to Report First Quarter 2023 Financial Results on May 4
April 20, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first...
Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
April 19, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the...
Codexis Announces New Employment Inducement Grants
April 06, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors
April 04, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the...
Codexis Announces New Employment Inducement Grants
March 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis to Participate in Cowen 43rd Annual Health Care Conference
February 27, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will participate in both a panel discussion...